Market Research Report
Global Injectable Drug Delivery Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023
|Published by||Occams Business Research & Consulting Pvt. Ltd.||Product code||536397|
|Published||Content info||190 Pages
Delivery time: Inquiry
|Global Injectable Drug Delivery Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023|
|Published: July 26, 2017||Content info: 190 Pages||
Injectable drug delivery is used for direct introduction of a pharmaceutical drug in body of the patient with the help of a delivery device. The global inject able drug delivery market is expected to rise at a CAGR of 12% during the forecast period 2016-2023. Growth in pharmaceutical and biotechnology industry is contributing to the growth of the global inject able drug delivery market. However, infection associated with needle stick injury is the factor restraining the growth of the global inject able drug delivery market during the forecast period.
Geographically, North America accounted for the largest market share in terms of revenue for inject able drug delivery market in 2016 and the region is expected to dominate the market during the forecast period followed by Europe. The dominance of the region is attributed to technologically advanced healthcare facilities in the countries of the region. However, Asia Pacific is expected to be the fastest growing region for inject able drug delivery market during the forecast period. The highest growth in the region is observed due to enhancing healthcare infrastructure and prevalence of chronic diseases in the region.
The growth in global inject able drug delivery market is also influenced by the presence of major players such as Baxter International (U.S.), Schott AG (Germany), Terumo Corporation (U.S.), Hospira Inc. (U.S.), Sanofi SA (France) etc. The market players adopt some crucial strategies such as product launches, partnerships, mergers & acquisitions etc.to gain competitive advantage.
Global inject able drug delivery market report covers segmentation analysis of type, formulation, therapeutic application, usage pattern and end users. Report further covers segmentsof type which includes device and formulations. Device is expected to dominate the segment during the forecast period owing to rising usage in management and control of various disorders at primary level. Formulation packaging in inject able drug delivery is divided as ampoules, bottles, cartridges and vials. Moreover, therapeutic applications of inject able drug delivery include auto immune diseases, hormonal disorders, oncology, orphan diseases and other applications. Oncology is expected to dominate the segment during the forecast period owing to increasing application of inject able drug delivery in diagnosis and treatment of cancer and diabetes. Furthermore, usage pattern segment of inject able drug delivery can be sub divided as curative care, immunization and others. Also, end users of inject able drug delivery include hospitals, homecare and others (Research institutes, clinical, diagnostic laboratories). Homecare segment is expected to dominate the segment during the forecast period owing to increasing demand for self-injection devices which provides easy administration of drugs at home without medical assistance.